Nintendo Co., Ltd. (0K85)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 13.57 |
|---|---|
| 52-week range | 10.15 – 22.83 |
| Return, 1 month / 3 months | +3.5% / +29.2% |
| Return, 1 year / 3 years | −36.6% / +34.5% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 42.0% |
| Worst drawdown (1 year) | -54.9% |
| Average daily value traded | 0.08M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nintendo Co., Ltd. is a Japanese entertainment company based in Kyoto that develops and publishes video games and the hardware on which they run. Its home consoles and handheld systems are sold to players around the world, and its software spans long-running series featuring characters such as Mario, Link and Pikachu, alongside newer titles. Nintendo also licenses its characters for merchandise, toys and theme park attractions, and it operates online services that let customers download games and play with others.
The shares are listed on the London Exchange in UK under the code 0K85, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nintendo Co., Ltd. (0K85) trades on the London Exchange in UK. It last closed at USD 13.57 on 23 October 2026.
Its price-based Market X-Ray is 40 out of 100 (a weak price profile), ranking 2,614 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 36.6% and over the last three months it rose 29.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 4.3% | ||
| From 52-week high | -40.0% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 29.2% | ||
| 6-month return | 5.8% | ||
| 12-month return, skipping the last month | -38.7% | ||
| Stability (higher is calmer) | 27 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 42.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -54.9% | ||
| Liquidity | 28 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.08M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.8% |
|---|---|
| 1 month | +3.5% |
| 3 months | +29.2% |
| 6 months | +5.8% |
| 1 year | −36.6% |
| 3 years | +34.5% |
| 5 years | +29.9% |
Signals
| 50-day / 200-day average | 13.29 / 13.01 |
|---|---|
| Golden / death cross (60 days) | Golden, 9 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.35 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Dec 2021 | JPY 2.8010 |
| 15 Jul 2021 | JPY 6.8918 |
| 16 Dec 2020 | JPY 3.8610 |
| 14 Jul 2020 | JPY 4.0054 |
| 17 Dec 2019 | JPY 1.1776 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.